Comparison of Whole Body DWI to FDG PET

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 6, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2029

Conditions
Metastatic Cancer
Interventions
DRUG

Fluorodeoxyglucose F18

Given IV as part of routine imaging

PROCEDURE

Positron Emission Tomography combined with Magnetic resonance imaging (PET/MRI)

Imaging procedure

PROCEDURE

Whole Body Magnetic Resonance Imaging with Diffusion-Weighted Imaging (WB-MRI-DWI)

Imaging procedure done concurrently with PET/MRI

DEVICE

General Electric (GE) SIGNA PET/MR

Imaging device

Trial Locations (1)

94143

RECRUITING

University of California, San Francisco, San Francisco

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Society of Abdominal Radiology

OTHER

collaborator

GE Healthcare

INDUSTRY

lead

University of California, San Francisco

OTHER

NCT06630845 - Comparison of Whole Body DWI to FDG PET | Biotech Hunter | Biotech Hunter